2 results
Approved WMOCompleted
Primary:• To determine the safety and tolerability of FHD-286 when administered as an oral monotherapy in subjects with metastatic uveal melanoma (UM)• To identify the maximum tolerated dose (MTD) and/or the recommended phase 2 dose (RP2D) of FHD-…
Approved WMOCompleted
To obtain user and medical staff feed-back on the safety, clinical performance and ergonomic features of the IPS and IBO.